You are here

Home

Treatments

FDA asks Pfizer to test second Paxlovid course in patients with COVID rebound

Fri, 2022-08-19 20:38 — mike kraft
FDA asks Pfizer to test second Paxlovid course in patients with COVID rebound The U.S. Food and Drug Administration (FDA) has ordered Pfizer Inc to test the effects of an additional course of its antiviral Paxlovid among people who experience a rebound in COVID-19 after treatment, the regulator said on Friday. Reuters Reuters

...

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Treatments
Disease
Disease Prevention
Government
Health
Medical Testing
Mutations
Pandemics
Public Health
Research
Problem, Solution, SitRep, or ?: 
Situation Report

How to assess risk for long term Covid issues--CNN

Fri, 2022-08-19 13:56 — mike kraft
Long Covid risk extends two years after infection. Here's how to assess your risk A new study found an increased risk of certain long Covid-19 symptoms up to two years after an original infection. Sandee LaMotte, CNN CNN

 

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Symptoms
Treatments
Disease
Disease Prevention
Mutations
Pandemics
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis

Ebola: WHO recommends use of two antibody drugs against Ebola

Fri, 2022-08-19 13:10 — mike kraft
WHO recommends use of two antibody drugs against Ebola The World Health Organization (WHO) on Friday recommended two monoclonal antibody treatments against Ebola, saying the use of such drugs combined with better care had "revolutionised" the treatment of a disease once seen as a near-certain killer. Reuters Reuters

...

Country / Region Tags: 
Africa
Conakry
Ghana
Guinea
Liberia
Nigeria
Sierra Leone
South Africa
United Nations
General Topic Tags: 
Treatments
Contagion
Disease
Disease Prevention
Health
Public Health
Research
Science
Problem, Solution, SitRep, or ?: 
Situation Report

Pages

Subscribe to Treatments
howdy folks
Page loaded in 0.566 seconds.